Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.

Six hundred and eighty-four primary breast cancers from the International (Ludwig) Breast Cancer Study Group (IBCSG) were studied for Helix pomatia lectin (HPA) binding. There was a weak correlation between lymph node-positive and HPA positive (P = 0.04). In our series there was a large advantage in...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968298/
https://www.ncbi.nlm.nih.gov/pubmed/8318406
_version_ 1782134709985214464
collection PubMed
description Six hundred and eighty-four primary breast cancers from the International (Ludwig) Breast Cancer Study Group (IBCSG) were studied for Helix pomatia lectin (HPA) binding. There was a weak correlation between lymph node-positive and HPA positive (P = 0.04). In our series there was a large advantage in disease-free survival (DFS) and overall survival (OS) for node-negative patients (P < 0.0001 DFS and OS). However, there was no such advantage for HPA-negative patients (P = 0.23 DFS and P = 0.32 OS). We conclude that in this randomised patient group HPA is of no clinical predictive value. IMAGES:
format Text
id pubmed-1968298
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19682982009-09-10 Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group. Br J Cancer Research Article Six hundred and eighty-four primary breast cancers from the International (Ludwig) Breast Cancer Study Group (IBCSG) were studied for Helix pomatia lectin (HPA) binding. There was a weak correlation between lymph node-positive and HPA positive (P = 0.04). In our series there was a large advantage in disease-free survival (DFS) and overall survival (OS) for node-negative patients (P < 0.0001 DFS and OS). However, there was no such advantage for HPA-negative patients (P = 0.23 DFS and P = 0.32 OS). We conclude that in this randomised patient group HPA is of no clinical predictive value. IMAGES: Nature Publishing Group 1993-07 /pmc/articles/PMC1968298/ /pubmed/8318406 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.
title Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.
title_full Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.
title_fullStr Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.
title_full_unstemmed Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.
title_short Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.
title_sort prognostic value of helix pomatia in breast cancer. international (ludwig) breast cancer study group.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968298/
https://www.ncbi.nlm.nih.gov/pubmed/8318406

Ejemplares similares